Kinnate Biopharma Inc. is a biotechnology company based in San Diego, California, focused on developing innovative therapies for cancer treatment. The company specializes in precision medicine, leveraging its expertise in drug discovery and development to target specific genetic mutations in tumors. Kinnate aims to address unmet medical needs by advancing its pipeline of targeted therapies, which are designed to improve outcomes for patients with various forms of cancer. Through its research, Kinnate is committed to transforming cancer care and enhancing patient quality of life.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

14 Patents

#389 in San Diego, CA

#5,322 in California

#22,333 in US

#42,290 in the World

San Diego, CA, United States of America

Kinnate Biopharma Inc.

Forward Citations = 44

15 inventors:

Toufike Kanouni (13 out of 86 patents)

Stephen W Kaldor (9 out of 68 patents)

Robert Steven Kania (8 out of 40 patents)

4. Jason M Cox (8 out of 32 patents)

5. Eric A Murphy (8 out of 15 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Kinnate Biopharma Inc.. Retrieved from https://idiyas.com/company/kinnate-biopharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]